Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Depressive disorders in adolescence, recurrence in early adulthood, and healthcare usage in mid-adulthood: A longitudinal cost-of-illness study.

Ssegonja R, Alaie I, Philipson A, Hagberg L, Sampaio F, Möller M, von Knorring L, Sarkadi A, Langenskiöld S, von Knorring AL, Bohman H, Jonsson U, Feldman I.

J Affect Disord. 2019 Nov 1;258:33-41. doi: 10.1016/j.jad.2019.07.077. Epub 2019 Jul 30.

PMID:
31382102
2.

Which patients benefit from physical activity on prescription (PAP)? A prospective observational analysis of factors that predict increased physical activity.

Lundqvist S, Börjesson M, Larsson MEH, Cider Å, Hagberg L.

BMC Public Health. 2019 May 2;19(1):482. doi: 10.1186/s12889-019-6830-1.

3.

Factors associated with blood culture positivity in patients with complicated skin and skin structure infection-a population-based study.

Halavaara M, Jääskeläinen IH, Hagberg L, Järvinen A.

Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1351-1357. doi: 10.1007/s10096-019-03560-9. Epub 2019 Apr 22.

4.

Uppsala Longitudinal Adolescent Depression Study (ULADS).

Alaie I, Philipson A, Ssegonja R, Hagberg L, Feldman I, Sampaio F, Möller M, Arinell H, Ramklint M, Päären A, von Knorring L, Olsson G, von Knorring AL, Bohman H, Jonsson U.

BMJ Open. 2019 Mar 1;9(3):e024939. doi: 10.1136/bmjopen-2018-024939.

5.

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection.

Hermansson L, Yilmaz A, Axelsson M, Blennow K, Fuchs D, Hagberg L, Lycke J, Zetterberg H, Gisslén M.

J Neuroinflammation. 2019 Jan 24;16(1):16. doi: 10.1186/s12974-019-1404-9.

6.

Cost-effectiveness and quality of life of a diet intervention postpartum: 2-year results from a randomized controlled trial.

Hagberg L, Winkvist A, Brekke HK, Bertz F, Hellebö Johansson E, Huseinovic E.

BMC Public Health. 2019 Jan 8;19(1):38. doi: 10.1186/s12889-018-6356-y.

7.

Cost-effectiveness of antibiotic prophylaxis in elective cesarean section.

Jansson MH, Cao Y, Nilsson K, Larsson PG, Hagberg L.

Cost Eff Resour Alloc. 2018 Dec 18;16:66. doi: 10.1186/s12962-018-0168-x. eCollection 2018.

8.

CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection.

Gisslén M, Heslegrave A, Veleva E, Yilmaz A, Andersson LM, Hagberg L, Spudich S, Fuchs D, Price RW, Zetterberg H.

Neurol Neuroimmunol Neuroinflamm. 2018 Nov 7;6(1):e512. doi: 10.1212/NXI.0000000000000512. eCollection 2019 Jan.

9.

Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.

Ulfhammer G, Edén A, Mellgren Å, Fuchs D, Zetterberg H, Hagberg L, Nilsson S, Yilmaz A, Gisslén M.

AIDS. 2018 Sep 24;32(15):2171-2178. doi: 10.1097/QAD.0000000000001950.

PMID:
30005007
10.

Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?

Burbelo PD, Price RW, Hagberg L, Hatano H, Spudich S, Deeks SG, Gisslén M.

J Infect Dis. 2018 Mar 13;217(7):1024-1032. doi: 10.1093/infdis/jix662.

11.

Cost-effectiveness of a systematic e-assessed follow-up of postoperative recovery after day surgery: a multicentre randomized trial.

Dahlberg K, Philipsson A, Hagberg L, Jaensson M, Hälleberg-Nyman M, Nilsson U.

Br J Anaesth. 2017 Nov 1;119(5):1039-1046. doi: 10.1093/bja/aex332.

12.

Osteomyelitis Risk in Patients With Transfemoral Amputations Treated With Osseointegration Prostheses.

Tillander J, Hagberg K, Berlin Ö, Hagberg L, Brånemark R.

Clin Orthop Relat Res. 2017 Dec;475(12):3100-3108. doi: 10.1007/s11999-017-5507-2. Epub 2017 Sep 22.

13.

Exocrine pancreatic insufficiency is common in people living with HIV on effective antiretroviral therapy.

Yilmaz A, Hagberg L.

Infect Dis (Lond). 2018 Mar;50(3):193-199. doi: 10.1080/23744235.2017.1370126. Epub 2017 Aug 25.

PMID:
28838283
14.

Quality of life and trust among young people with narcolepsy and their families, after the Pandemrix® vaccination: protocol for a case-control study.

Blomberg K, Carlsson AA, Hagberg L, Jonsson Ö, Leissner L, Eriksson MH.

BMC Pediatr. 2017 Aug 23;17(1):183. doi: 10.1186/s12887-017-0935-4.

15.

A potential benefit from infectious disease specialist and stationary ward in rational antibiotic therapy of complicated skin and skin structure infections.

Jääskeläinen IH, Hagberg L, Schyman T, Järvinen A.

Infect Dis (Lond). 2018 Feb;50(2):107-116. doi: 10.1080/23744235.2017.1362706. Epub 2017 Aug 8.

PMID:
28789580
16.

Motivation to uphold physical activity in women with breast cancer during adjuvant chemotherapy treatment.

Wilhelmsson A, Roos M, Hagberg L, Wengström Y, Blomberg K.

Eur J Oncol Nurs. 2017 Aug;29:17-22. doi: 10.1016/j.ejon.2017.03.008. Epub 2017 May 3.

PMID:
28720261
17.

Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.

Yilmaz A, Blennow K, Hagberg L, Nilsson S, Price RW, Schouten J, Spudich S, Underwood J, Zetterberg H, Gisslén M.

Expert Rev Mol Diagn. 2017 Aug;17(8):761-770. doi: 10.1080/14737159.2017.1341313. Epub 2017 Jun 14. Review.

PMID:
28598205
18.

Microbiological Etiology and Treatment of Complicated Skin and Skin Structure Infections in Diabetic and Nondiabetic Patients in a Population-Based Study.

Jääskeläinen IH, Hagberg L, Forsblom E, Järvinen A.

Open Forum Infect Dis. 2017 Mar 10;4(2):ofx044. doi: 10.1093/ofid/ofx044. eCollection 2017 Spring.

19.

Physical Activity on Prescription (PAP), in patients with metabolic risk factors. A 6-month follow-up study in primary health care.

Lundqvist S, Börjesson M, Larsson ME, Hagberg L, Cider Å.

PLoS One. 2017 Apr 12;12(4):e0175190. doi: 10.1371/journal.pone.0175190. eCollection 2017.

20.

We Propose a Novel Measure for Social Welfare and Public Health: Capability-Adjusted Life-Years, CALYs.

Månsdotter A, Ekman B, Feldman I, Hagberg L, Hurtig AK, Lindholm L.

Appl Health Econ Health Policy. 2017 Aug;15(4):437-440. doi: 10.1007/s40258-017-0323-0. No abstract available.

PMID:
28374165
21.

Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.

Rahimy E, Li FY, Hagberg L, Fuchs D, Robertson K, Meyerhoff DJ, Zetterberg H, Price RW, Gisslén M, Spudich S.

J Infect Dis. 2017 Apr 1;215(7):1132-1140. doi: 10.1093/infdis/jix013.

22.

Factors associated with time to clinical stability in complicated skin and skin structure infections.

Jääskeläinen IH, Hagberg L, Forsblom E, Järvinen A.

Clin Microbiol Infect. 2017 Sep;23(9):674.e1-674.e5. doi: 10.1016/j.cmi.2017.02.033. Epub 2017 Mar 6.

23.

Costs and resource use following defunctioning stoma in low anterior resection for cancer - A long-term analysis of a randomized multicenter trial.

Floodeen H, Hallböök O, Hagberg LA, Matthiessen P.

Eur J Surg Oncol. 2017 Feb;43(2):330-336. doi: 10.1016/j.ejso.2016.12.003. Epub 2016 Dec 21.

PMID:
28069399
24.

Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV.

Anesten B, Yilmaz A, Hagberg L, Zetterberg H, Nilsson S, Brew BJ, Fuchs D, Price RW, Gisslén M.

Neurol Neuroimmunol Neuroinflamm. 2016 Nov 9;3(6):e300. eCollection 2016 Dec.

25.

Case management at an outpatient unit for severe and enduring eating disorder patients at Stockholm Centre for Eating Disorders- a study protocol.

Molin M, von Hausswolff-Juhlin Y, Norring C, Hagberg L, Gustafsson SA.

J Eat Disord. 2016 Oct 26;4:24. eCollection 2016.

26.

Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.

Edén A, Nilsson S, Hagberg L, Fuchs D, Zetterberg H, Svennerholm B, Gisslén M.

J Infect Dis. 2016 Dec 15;214(12):1822-1825. Epub 2016 Sep 28.

PMID:
27683820
27.

Biofilm formation and antimicrobial susceptibility of staphylococci and enterococci from osteomyelitis associated with percutaneous orthopaedic implants.

Zaborowska M, Tillander J, Brånemark R, Hagberg L, Thomsen P, Trobos M.

J Biomed Mater Res B Appl Biomater. 2017 Nov;105(8):2630-2640. doi: 10.1002/jbm.b.33803. Epub 2016 Oct 25.

PMID:
27779811
28.

Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection.

Ahlgren E, Hagberg L, Fuchs D, Andersson LM, Nilsson S, Zetterberg H, Gisslén M.

PLoS One. 2016 Jul 21;11(7):e0158973. doi: 10.1371/journal.pone.0158973. eCollection 2016.

29.

No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).

Krut JJ, Price RW, Zetterberg H, Fuchs D, Hagberg L, Yilmaz A, Cinque P, Nilsson S, Gisslén M.

Virulence. 2017 Jul 4;8(5):599-604. doi: 10.1080/21505594.2016.1212155. Epub 2016 Jul 19.

30.

Corrigendum to: "Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: A cross-sectional study" [EBioMedicine 3 (216) 135-140].

Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H.

EBioMedicine. 2016 May;7:287-288. doi: 10.1016/j.ebiom.2016.04.021. Epub 2016 Apr 20. No abstract available.

31.

Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.

Jespersen S, Pedersen KK, Anesten B, Zetterberg H, Fuchs D, Gisslén M, Hagberg L, Trøseid M, Nielsen SD.

BMC Infect Dis. 2016 Apr 21;16:176. doi: 10.1186/s12879-016-1510-6.

32.

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.

Gisslén M, Price RW, Andreasson U, Norgren N, Nilsson S, Hagberg L, Fuchs D, Spudich S, Blennow K, Zetterberg H.

EBioMedicine. 2015 Nov 22;3:135-140. doi: 10.1016/j.ebiom.2015.11.036. eCollection 2016 Jan. Erratum in: EBioMedicine. 2016 May;7:287-288.

33.

Treatment of complicated skin and skin structure infections in areas with low incidence of antibiotic resistance-a retrospective population based study from Finland and Sweden.

Jääskeläinen IH, Hagberg L, From J, Schyman T, Lehtola L, Järvinen A.

Clin Microbiol Infect. 2016 Apr;22(4):383.e1-383.e10. doi: 10.1016/j.cmi.2016.01.002. Epub 2016 Jan 20.

35.

Cerebrospinal fluid markers of central nervous system injury in decompression illness - a case-controlled pilot study.

Shahim P, Arnell P, Kvarnström A, Rosén A, Bremell D, Hagberg L, Blennow K, Zetterberg H.

Diving Hyperb Med. 2015 Dec;45(4):240-3.

PMID:
26687311
36.

[Scrap the Centor criteria in tonsillitis].

Strömberg A, Roos K, Hagberg L.

Lakartidningen. 2015 Oct 12;112. pii: DREZ. Swedish. No abstract available.

37.

Time window for positive cerebrospinal fluid broad-range bacterial PCR and Streptococcus pneumoniae immunochromatographic test in acute bacterial meningitis.

Brink M, Welinder-Olsson C, Hagberg L.

Infect Dis (Lond). 2015;47(12):869-77. doi: 10.3109/23744235.2015.1078907. Epub 2015 Aug 24.

PMID:
26305587
38.

The effect of powered scooters on activity, participation and quality of life in elderly users.

Pettersson I, Hagberg L, Fredriksson C, Hermansson LN.

Disabil Rehabil Assist Technol. 2016 Oct;11(7):558-63. doi: 10.3109/17483107.2015.1027301. Epub 2015 Mar 24.

PMID:
25799878
39.

Cost-effectiveness of powered mobility devices for elderly people with disability.

Hagberg L, Hermansson L, Fredriksson C, Pettersson I.

Disabil Rehabil Assist Technol. 2017 Feb;12(2):115-120. Epub 2015 Jan 30.

PMID:
25634493
40.

Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.

Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, Yiannoutsos CT, Spudich SS, Price RW.

PLoS One. 2014 Dec 26;9(12):e116081. doi: 10.1371/journal.pone.0116081. eCollection 2014.

41.

Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection.

Suh J, Sinclair E, Peterson J, Lee E, Kyriakides TC, Li FY, Hagberg L, Fuchs D, Price RW, Gisslen M, Spudich S.

J Neuroinflammation. 2014 Dec 3;11:199. doi: 10.1186/s12974-014-0199-y.

42.

PXL01 in sodium hyaluronate for improvement of hand recovery after flexor tendon repair surgery: randomized controlled trial.

Wiig ME, Dahlin LB, Fridén J, Hagberg L, Larsen SE, Wiklund K, Mahlapuu M.

PLoS One. 2014 Oct 23;9(10):e110735. doi: 10.1371/journal.pone.0110735. eCollection 2014.

43.

A series of severe necrotising soft-tissue infections in a regional centre in Sweden.

Brink M, Arnell P, Lycke H, Rosemar A, Hagberg L.

Acta Anaesthesiol Scand. 2014 Aug;58(7):882-90. doi: 10.1111/aas.12345. Epub 2014 Jun 13.

PMID:
24924532
44.

Neurochemical evidence of potential neurotoxicity after prophylactic cranial irradiation.

Kalm M, Abel E, Wasling P, Nyman J, Hietala MA, Bremell D, Hagberg L, Elam M, Blennow K, Björk-Eriksson T, Zetterberg H.

Int J Radiat Oncol Biol Phys. 2014 Jul 1;89(3):607-14. doi: 10.1016/j.ijrobp.2014.03.019. Epub 2014 May 3.

PMID:
24803034
45.

Distinct inflammatory mediator patterns characterize infectious and sterile systemic inflammation in febrile neutropenic hematology patients.

Wennerås C, Hagberg L, Andersson R, Hynsjö L, Lindahl A, Okroj M, Blom AM, Johansson P, Andreasson B, Gottfries J, Wold AE.

PLoS One. 2014 Mar 18;9(3):e92319. doi: 10.1371/journal.pone.0092319. eCollection 2014.

46.

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.

Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L, Nilsson S, Zetterberg H, Gisslén M.

PLoS One. 2014 Feb 11;9(2):e88591. doi: 10.1371/journal.pone.0088591. eCollection 2014.

47.

Cost-utility analysis of a randomized controlled weight loss trial among lactating overweight/obese women.

Hagberg LA, Brekke HK, Bertz F, Winkvist A.

BMC Public Health. 2014 Jan 15;14:38. doi: 10.1186/1471-2458-14-38.

48.

An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy.

Dahl V, Gisslen M, Hagberg L, Peterson J, Shao W, Spudich S, Price RW, Palmer S.

J Infect Dis. 2014 May 15;209(10):1618-22. doi: 10.1093/infdis/jit805. Epub 2013 Dec 12.

49.

Automated cerebrospinal fluid cell count--new reference ranges and evaluation of its clinical use in central nervous system infections.

Bremell D, Mattsson N, Wallin F, Henriksson J, Wall M, Blennow K, Zetterberg H, Hagberg L.

Clin Biochem. 2014 Jan;47(1-2):25-30. doi: 10.1016/j.clinbiochem.2013.11.010. Epub 2013 Nov 22.

PMID:
24275252
50.

Are lifestyle interventions in primary care cost-effective?--An analysis based on a Markov model, differences-in-differences approach and the Swedish Björknäs study.

Saha S, Carlsson KS, Gerdtham UG, Eriksson MK, Hagberg L, Eliasson M, Johansson P.

PLoS One. 2013 Nov 14;8(11):e80672. doi: 10.1371/journal.pone.0080672. eCollection 2013.

Supplemental Content

Loading ...
Support Center